National Interstate Corporation Announces Timing of Third Quarter Earnings Release
Oct 14, 2016 11:30 am UTC| Business
RICHFIELD, Ohio, Oct. 14, 2016 -- National Interstate Corporation (Nasdaq:NATL) announced today that the Company expects to release its 2016 third quarter results after the market closes on Tuesday, November 1, 2016....
Oxford Announces Webcast of 2016 Investor Day
Oct 14, 2016 11:30 am UTC| Business
ATLANTA, Oct. 14, 2016 -- Oxford Industries, Inc. (NYSE:OXM) today announced that it will webcast its 2016 Investor Day on Tuesday, October 18, 2016 beginning at 3:00 p.m. ET. The event, to be held in New York City,...
Adverum Biotechnologies Provides Update on Alpha-1 Antitrypsin Deficiency Program
Oct 14, 2016 11:01 am UTC| Business
MENLO PARK, Calif., Oct. 14, 2016 -- Adverum Biotechnologies, Inc. (Nasdaq:ADVM) today provided an update on its development program for ADVM-043 (formerly “ANN-001”), a novel gene therapy for Alpha-1 Antitrypsin (A1AT)...
Adverum Biotechnologies, Inc. Announces New Executive Chair and CEO
Oct 14, 2016 11:00 am UTC| Business
Paul Cleveland Named Executive Chairman of the Board Amber Salzman, Ph.D. Named CEO MENLO PARK, Calif., Oct. 14, 2016 -- Adverum Biotechnologies, Inc. (Nasdaq:ADVM), a gene therapy company committed to...
Intellia Therapeutics to Present Data at the European Society of Gene & Cell Therapy Congress
Oct 14, 2016 11:00 am UTC| Business
CAMBRIDGE, Mass., Oct. 14, 2016 -- Intellia Therapeutics, Inc. (NASDAQ:NTLA),a leading genome editing company focused on the development of potentially curative therapeutics using CRISPR/Cas9 technology, announced that...
Broadwind To Announce Q3 2016 Results on October 28
Oct 14, 2016 11:00 am UTC| Business
CICERO, Ill., Oct. 14, 2016 -- Broadwind Energy, Inc. (NASDAQ:BWEN) will announce third quarter 2016 results on Friday, October 28, 2016 before market open. An investor conference call will follow at 10 a.m. Central...
Akari Therapeutics Appoints New Members to its Board of Directors
Oct 14, 2016 11:00 am UTC| Business
NEW YORK and LONDON, Oct. 14, 2016 -- Akari Therapeutics (NASDAQ:AKTX), an emerging growth, clinical-stage biopharmaceutical company, announced today the appointment of Robert Ward to its Board of Directors. Mr. Ward...